{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:31:10Z","timestamp":1785814270613,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AR232\/17-1"],"award-info":[{"award-number":["AR232\/17-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FR2545\/2-1"],"award-info":[{"award-number":["FR2545\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bbr.2012.11.011","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T18:03:37Z","timestamp":1353521017000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of complete vagotomy and blockage of cell adhesion molecules on interferon-\u03b1 induced behavioral changes in mice"],"prefix":"10.1016","volume":"240","author":[{"given":"Astrid","family":"Friebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Br\u00fcnahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Juckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Sakic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Arck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","article-title":"Sickness behavior as a new target for drug development","volume":"13","author":"Kent","year":"1992","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.bbr.2012.11.011_bib0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","article-title":"Cytokine-induced sickness behavior: mechanisms and implications","volume":"933","author":"Dantzer","year":"2001","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/j.bbr.2012.11.011_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain, Behavior, and Immunity"},{"issue":"5","key":"10.1016\/j.bbr.2012.11.011_bib0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1188\/08.ONF.802-807","article-title":"Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms","volume":"35","author":"Myers","year":"2008","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.bbr.2012.11.011_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-0-585-37970-8_16","article-title":"Cytokines, \u201cdepression due to a general medical condition\u201d, and antidepressant drugs","volume":"461","author":"Yirmiya","year":"1999","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"13","key":"10.1016\/j.bbr.2012.11.011_bib0030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2174\/138161208799316375","article-title":"Proinflammatory cytokines and sickness behavior in rheumatic diseases","volume":"14","author":"Lorton","year":"2008","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1016\/j.bbr.2012.11.011_bib0035","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1572-0241.2008.01980.x","article-title":"The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders","volume":"103","author":"Walker","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.bbr.2012.11.011_bib0040","first-page":"230","article-title":"Update on the role of adjuvant interferon for high risk melanoma","volume":"10","author":"Agarwala","year":"2000","journal-title":"Forum"},{"issue":"6","key":"10.1016\/j.bbr.2012.11.011_bib0045","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/jhep.2000.7880","article-title":"Hepatitis C, interferon alfa, and depression","volume":"31","author":"Zdilar","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bbr.2012.11.011_bib0050","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review","volume":"157","author":"Dieperink","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2012.11.011_bib0055","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2012.11.011_bib0060","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","article-title":"Interferon alpha (IFNalpha) and psychiatric syndromes: a review","volume":"26","author":"Schaefer","year":"2002","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2012.11.011_bib0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.cji.0000211346.19330.c9","article-title":"Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma","volume":"30","author":"Friebe","year":"2007","journal-title":"Journal of Immunotherapy"},{"issue":"6","key":"10.1016\/j.bbr.2012.11.011_bib0070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","article-title":"Brain\u2013immune communication pathways","volume":"21","author":"Quan","year":"2007","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/j.bbr.2012.11.011_bib0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.iac.2009.02.001","article-title":"The blood\u2013brain barrier in psychoneuroimmunology","volume":"29","author":"Banks","year":"2009","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","article-title":"The blood\u2013brain barrier and immune function and dysfunction","volume":"37","author":"Banks","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"11","key":"10.1016\/j.bbr.2012.11.011_bib0085","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0024-3205(95)02047-M","article-title":"Cytokine-to-brain communication: a review & analysis of alternative mechanisms","volume":"57","author":"Watkins","year":"1995","journal-title":"Life Sciences"},{"issue":"6","key":"10.1016\/j.bbr.2012.11.011_bib0090","first-page":"499","article-title":"Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism","volume":"317","author":"Bluth\u00e9","year":"1994","journal-title":"Comptes Rendus de l Academie des Sciences. Serie III, Sciences de la Vie"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2012.11.011_bib0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1566-0702(00)00231-9","article-title":"Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats","volume":"85","author":"Luheshi","year":"2000","journal-title":"Autonomic Neuroscience"},{"issue":"6","key":"10.1016\/j.bbr.2012.11.011_bib0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbi.2004.02.002","article-title":"Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha","volume":"18","author":"Schaefer","year":"2004","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/j.bbr.2012.11.011_bib0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni1551","article-title":"Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system","volume":"9","author":"Cayrol","year":"2008","journal-title":"Nature Immunology"},{"issue":"4","key":"10.1016\/j.bbr.2012.11.011_bib0110","doi-asserted-by":"crossref","first-page":"R1131","DOI":"10.1152\/ajpregu.90434.2008","article-title":"Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve","volume":"295","author":"Van der Kleij","year":"2008","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-1838(83)90148-0","article-title":"Altered endocrine pancreatic function following vagotomy: possible behavioral and metabolic bases for assessing completeness of vagotomy","volume":"9","author":"Campfield","year":"1983","journal-title":"Journal of the Autonomic Nervous System"},{"issue":"4","key":"10.1016\/j.bbr.2012.11.011_bib0120","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4049\/jimmunol.174.4.1820","article-title":"Intercellular adhesion molecule-1\/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies","volume":"174","author":"Blois","year":"2005","journal-title":"Journal of Immunology"},{"issue":"5","key":"10.1016\/j.bbr.2012.11.011_bib0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","article-title":"Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior","volume":"32","author":"Frenois","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.bbr.2012.11.011_bib0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.bbr.2012.11.011_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000397","article-title":"Molecular targets for disrupting leukocyte trafficking during multiple sclerosis","volume":"9","author":"McCandless","year":"2007","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4049\/jimmunol.0802684","article-title":"Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b","volume":"183","author":"Huston","year":"2009","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.surge.2010.07.011","article-title":"Surgery induced immunosuppression","volume":"9","author":"Hogan","year":"2011","journal-title":"Surgeon"},{"key":"10.1016\/j.bbr.2012.11.011_bib0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/00365513.2012.721520","article-title":"Human monocyte responses to lipopolysaccharide and 9-cis retinoic acid after laparoscopic surgery for colon cancer","volume":"72","author":"Kolseth","year":"2012","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"issue":"6","key":"10.1016\/j.bbr.2012.11.011_bib0160","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbi.2010.03.010","article-title":"Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression","volume":"24","author":"Avraham","year":"2010","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.bbr.2012.11.011_bib0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1034\/j.1399-6576.2002.460413.x","article-title":"Influence of surgery and endotoxin-induced sepsis combined on natural killer cell activity, oxidative burst of granulocytes and antigen presentation capability of monocytes","volume":"46","author":"Toft","year":"2002","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00474-9","article-title":"Enhancement of immobility in mouse forced swimming test by treatment with human interferon","volume":"356","author":"Makino","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s002130050031","article-title":"Human interferon-alpha increases immobility in the forced swimming test in rats","volume":"148","author":"Makino","year":"2000","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2012.11.011_bib0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0006-8993(99)02235-0","article-title":"Human interferon-alpha induces immobility in the mouse forced swimming test: involvement of the opioid system","volume":"852","author":"Makino","year":"2000","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.bbr.2012.11.011_bib0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0306-4530(00)00051-2","article-title":"Acute interferon-alpha administration modulates sucrose consumption in the rat","volume":"26","author":"Sammut","year":"2000","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbr.2012.11.011_bib0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbr.2007.05.005","article-title":"The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats","volume":"182","author":"Fahey","year":"2007","journal-title":"Behavioural Brain Research"},{"issue":"5","key":"10.1016\/j.bbr.2012.11.011_bib0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.pnpbp.2005.03.008","article-title":"Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats","volume":"29","author":"De La Garza","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"10","key":"10.1016\/j.bbr.2012.11.011_bib0200","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.psyneuen.2006.07.006","article-title":"Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats","volume":"31","author":"Loftis","year":"2006","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.bbr.2012.11.011_bib0205","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.pnpbp.2006.04.004","article-title":"Can rodents be used to model interferon-alpha-induced depressive symptoms?","volume":"30","author":"Loftis","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2012.11.011_bib0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2009.01.050","article-title":"Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover","volume":"452","author":"Wang","year":"2009","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.bbr.2012.11.011_bib0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FBP.0b013e32832a805e","article-title":"Interferon-alpha reinstates morphine-conditioned place preference through opioid receptors in rats","volume":"20","author":"Lang","year":"2009","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.bbr.2012.11.011_bib0220","first-page":"466","article-title":"Dose dependent development of depressive symptoms during adjuvant interferon-alpha treatment of patients with malignant melanoma","volume":"51","author":"Friebe","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.bbr.2012.11.011_bib0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(95)11452-3","article-title":"Microglial localization of a-interferon receptor in human brain tissues","volume":"189","author":"Yamada","year":"1995","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbr.2012.11.011_bib0230","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.0602460103","article-title":"Neurons produce type I interferon during viral encephalitis","volume":"103","author":"Delhaye","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.11.011_bib0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jneuroim.2004.09.013","article-title":"Effects of interferon-beta on the cytokine production of astrocytes","volume":"159","author":"Okada","year":"2005","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.bbr.2012.11.011_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(97)00029-5","article-title":"Is interferon-\u03b1 a neuromodulator?","volume":"26","author":"Dafny","year":"1998","journal-title":"Brain Research Reviews"},{"issue":"1 Suppl. 1","key":"10.1016\/j.bbr.2012.11.011_bib0245","first-page":"23","article-title":"The effects of interferon-alpha on the production and action of other cytokines","volume":"25","author":"Taylor","year":"1998","journal-title":"Seminars in Oncology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2012.11.011_bib0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-1781(01)00315-8","article-title":"Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms","volume":"105","author":"Bonaccorso","year":"2001","journal-title":"Psychiatry Research"},{"issue":"Pt 3","key":"10.1016\/j.bbr.2012.11.011_bib0255","first-page":"470","article-title":"The afferent signalling of fever","volume":"526","author":"Blatteis","year":"2000","journal-title":"Journal of Physiology"},{"issue":"4","key":"10.1016\/j.bbr.2012.11.011_bib0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood\u2013brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2012.11.011_bib0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-5728(97)00034-9","article-title":"Permeability of the blood\u2013brain and blood\u2013spinal cord barriers to interferons","volume":"76","author":"Pan","year":"1997","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.bbr.2012.11.011_bib0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(91)90639-D","article-title":"Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis","volume":"562","author":"Shibata","year":"1991","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.11.011_bib0275","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1523\/JNEUROSCI.18-22-09471.1998","article-title":"Activation of vagal afferents after intravenous injection of interleukin-1b: role of endogenous prostaglandins","volume":"18","author":"Ek","year":"1998","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.011_bib0280","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-065X.2012.01138.x","article-title":"Rethinking inflammation: neural circuits in the regulation of immunity","volume":"248","author":"Olofsson","year":"2012","journal-title":"Immunological Reviews"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812007334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812007334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:14:31Z","timestamp":1764105271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812007334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":56,"alternative-id":["S0166432812007334"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.11.011","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of complete vagotomy and blockage of cell adhesion molecules on interferon-\u03b1 induced behavioral changes in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2012.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}